Immune thrombocytopenic purpura

Area of Science:

• Hematology
• Immunology

Background:

• Immune thrombocytopenic purpura (ITP) is a bleeding disorder defined by isolated thrombocytopenia (<150,000 platelets/µL) unrelated to systemic illness.
• ITP affects approximately 2 in 100,000 adults, with a mean age of diagnosis around 50 years, and is more prevalent in women of childbearing age and during pregnancy.

Purpose of the Study:

• To emphasize the importance of accurate diagnosis and timely management of immune thrombocytopenic purpura (ITP).
• To highlight the role of primary care physicians in identifying and initiating treatment for ITP.

Main Methods:

• This review synthesizes current understanding of ITP diagnosis and management.
• It underscores the necessity of excluding other causes of thrombocytopenia, as ITP is a diagnosis of exclusion.

Main Results:

• Prompt recognition of thrombocytopenia symptoms like petechiae and purpura is essential.
• A high index of clinical suspicion aids in accurate ITP diagnosis.

Conclusions:

• Early and accurate diagnosis of ITP is critical.
• Initiating appropriate treatment, such as glucocorticoids, improves patient prognosis.